Evidence map›Paper›PMID 9763604›Full record

ArticleThe Journal of experimental medicine1998

Regulation of anti-DNA B cells in recombination-activating gene-deficient mice.

H Xu, H Li, E Suri-Payer, R R Hardy, M Weigert

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Central B-cell tolerance: where selection begins.Cold Spring Harbor perspectives in biology · 2012
    Article
  6. Article
  7. B cell receptor editing in tolerance and autoimmunity.Annals of the New York Academy of Sciences · 2011
    Review
  8. Article
  9. Editing and escape from editing in anti-DNA B cells.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The evolution of human anti-double-stranded DNA autoantibodies.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  15. Human autoantibody silencing by immunoglobulin light chains.The Journal of experimental medicine · 2004
    Article
  16. Article
  17. Article
  18. Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  19. B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  20. A B-cell receptor-specific selection step governs immature to mature B cell differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

H XuDepartment of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA.
H Li
E Suri-Payer
R R Hardy
M Weigert
Fox Chase Cancer Center · USPrinceton University · US

Funding

THE GENETIC CONTROL OF ANTIBODY DIVERSITY AND EXPRESSIONR01GM020964 · NIGMS · UNIVERSITY OF CHICAGO · PI WEIGERT, MARTIN G · 1985 to 2011
$5.7M
GENETIC CONTROL OF THE ANTIBODY STRUCTURER37GM020964 · NIGMS · PRINCETON UNIVERSITY · PI WEIGERT, MARTIN G · 1987 to 1996
–
NIGMS NIH HHS GM-20964-24NIGMS NIH HHS R01 GM020964
6 · The paper itself

Abstract

Anti-DNA antibodies are regulated in normal individuals but are found in high concentration in the serum of systemic lupus erythematosus (SLE) patients and the MRL lpr/lpr mouse model of SLE. We previously studied the regulation of anti-double-stranded (ds)DNA and anti-single-stranded (ss)DNA B cells in a nonautoimmune background by generating mice carrying immunoglobulin transgenes coding for anti-DNAs derived from MRL lpr/lpr. Anti-dsDNA B cells undergo receptor editing, but anti-ssDNA B cells seem to be functionally silenced. Here we have investigated how anti-DNA B cells are regulated in recombination- activating gene (RAG)-2-/- mice. In this setting, anti-dsDNA B cells are eliminated by apoptosis in the bone marrow and anti-ssDNA B cells are partially activated.

Indexed as

AnimalsAntibodies, AntinuclearApoptosisB-LymphocytesDNA-Binding ProteinsDNA, Single-StrandedMiceMice, KnockoutRecombination, GeneticAntibodies, AntinuclearDNA-Binding ProteinsDNA, Single-StrandedRag2 protein, mouseV(D)J recombination activating protein 2

Identifiers

PMID9763604
PMCPMC2212494
OpenAlexW2010072801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.